Katakura Industries Co.,Ltd.

Katakura Industries Co.,Ltd. engages in the textile, pharmaceutical, machinery, real estate, and life solutions businesses in Japan. The company manufactures and sells undergarments, hosiery products, aprons, and relaxing garments, as well as various functional fibers, such as the water-soluble fiber solvron and the thermal resistant NITIVY ALF. It also engages in the manufacture and sale of pharmaceuticals for treating cardiovascular illnesses comprising Frandol for the treatment of angina pectoris; and Frandol Tape, a heart medicine. In addition, the company manufactures and sells environment-related equipment (washers) and cutting oil–related products, fire engines and firefighting-related equipment, and agricultural machinery, as well as car parts. Further, it provides commercial facility management services; and leases and develops various real estate lands. Additionally, the company offers agriculture-related products, food products, nursing care equipment, and general building maintenance and flower/tree planting services, as well as operates plant and pet specialty shops. The company was formerly known as Katakura Silk Spinning Co., Ltd. and changed its name to Katakura Industries Co.,Ltd. in November 1943. Katakura Industries Co.,Ltd. was founded in 1873 and is headquartered in Tokyo, Japan.

Katakura Industries Co.,Ltd. trades as KKRAF on OTC. The company is classified in Industrials / Conglomerates and reports in USD.

The current profile places the business in Conglomerates. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $40.69B of revenue and $5.77B of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Katakura Industries Co.,Ltd. can be compared against peers such as Diversified Royalty Corp., Mersen S.A., Ellaktor S.A., GL Events S.A., INDUS Holding AG, Raksul Inc..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $544.69M, beta of 0.31, and return on equity of +5.9%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

KKRAF currently shows total debt of $7.69B and beta of 0.31. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.katakura.co.jp

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.